ITM OncoBeta GmbH is responsible for the industrialization, CE certification and business development of the ITM Rhenium-SCT™ - a highly effective, novelty treatment for skin cancers.

It is OncoBetas main current task to finalize the product development for the proprietary application system and receive CE-certification for the ITM Rhenium-SCT™ in the first quarter of 2011. In parallel the pilot operations and market entries in Germany, Italy and Australia are prepared through regional subsidiaries and collaborations.

For further information please contact:

• This e-mail address is being protected from spambots. You need JavaScript enabled to view it

OncoBeta GmbH

Lichtenbergstraße 1
85748 Garching
Germany
Phone: +49 89 289-13938